-
Broussonetia papyrifera in Alzheimer’s Pathogenesis
2026-08-26
A 2026 Journal of Ethnopharmacology study shows that the ethyl acetate fraction of Broussonetia papyrifera fruit can reduce amyloid-beta proteotoxicity while interrupting oxidative and mitochondrial stress in Caenorhabditis elegans and cellular models. Its value lies in linking behavioral, pathological, mitochondrial, antioxidant, apoptotic, and transcriptomic readouts rather than treating amyloid aggregation and oxidative damage as separate processes.
-
ConA Targets Conserved Coronavirus Spike Glycans
2026-08-25
Guo et al. identify conserved high-mannose N-glycosylation sites near the coronavirus spike S2′ cleavage site as a broad-spectrum antiviral vulnerability. Using fusion, pseudovirus, authentic-virus, biochemical, and mouse infection models, the study shows that concanavalin A blocks spike activation and viral entry, while also suggesting how imaging workflows could support structural investigation of glycan-dependent mechanisms.
-
AZD3463: ALK/IGF1R Workflow Guide
2026-08-25
AZD3463 is a dual-target ALK/IGF1R inhibitor for pathway-resolved neuroblastoma experiments, mutant-ALK profiling, and chemotherapy combination studies. This bench guide connects dose design, PI3K/AKT/mTOR readouts, apoptosis and autophagy assays, and pathway cross-talk concepts to practical troubleshooting.
-
Humanized Gs-DREADD for Circuit Modulation
2026-08-24
Zhang and colleagues developed hM3Ds, a whole-sequence-humanized Gs-coupled DREADD designed to retain the ligand responsiveness of rM3Ds while reducing concerns associated with a non-human receptor backbone. In mice, selective hM3Ds activation in D1 medium spiny neurons engaged the basal ganglia direct pathway and improved Parkinsonian phenotypes, supporting its value as a research tool and a candidate for future translational development.
-
T-5224 for AP-1 Inflammation Research
2026-08-24
T-5224 is a selective C-Fos/AP-1 inhibitor for separating c-Fos/c-Jun transcriptional activity from broader inflammatory signaling. This practical guide connects arthritis workflows with a hypothesis-testing strategy for neuroinflammatory pain while clearly distinguishing established evidence from new applications.
-
3-Deazaadenosine in Fibrosis: From SAHH to m6A
2026-08-23
A translational framework for using 3-Deazaadenosine hydrochloride to interrogate SAHH-dependent methyl metabolism in hepatic stellate cell activation, while separating mechanistic evidence from assay strategy and therapeutic speculation.
-
IGF2BP1–TUBB4B Axis in Liver Fibrosis
2026-08-22
The reference study identifies an m6A-dependent IGF2BP1–TUBB4B–FAK pathway that promotes hepatic stellate cell activation, proliferation, and migration. By integrating transcriptomic and molecular validation, it connects an RNA-stability mechanism with fibrogenic signaling and highlights a testable framework for antifibrotic research.
-
10 mM dNTP Mixture: Assay Design & LNP Insight
2026-08-22
Explore how a 10 mM dNTP mixture supports controlled DNA synthesis while clarifying what nucleotide quality can—and cannot—tell you about lipid nanoparticle trafficking. This evidence-led guide connects reagent design, assay controls, and mechanistic interpretation.
-
3-Deazaadenosine Hydrochloride in Methylation Assays
2026-08-21
3-Deazaadenosine hydrochloride is a selective S-adenosylhomocysteine hydrolase inhibitor for interrogating methylation-dependent biology. This guide shows how to use it as a mechanistic perturbation alongside the IGF2BP1–m6A–TUBB4B pathway in hepatic stellate cell research, while avoiding overinterpretation of downstream phenotypes.
-
Tacrine hydrochloride hydrate for AD Assays
2026-08-20
Tacrine hydrochloride hydrate is a practical benchmark for connecting acetylcholinesterase inhibition with downstream neuroprotection assays. This guide shows how to use Tetrahydroaminacrine in enzyme, cellular, and neurodegenerative disease model workflows while separating target engagement from toxicity.
-
HyperScribe T7 Cy5 RNA Labeling Kit Guide
2026-08-20
The HyperScribe T7 High Yield Cy5 RNA Labeling Kit is a 25-reaction Cy5 RNA labeling kit for T7-driven in vitro transcription RNA labeling. Its adjustable Cy5-UTP substitution supports fluorescent RNA probe synthesis for in situ hybridization and Northern blot hybridization, while the cited TREM2 study provides biological context for macrophage and inflammatory disease research rather than direct kit validation.
-
IGF2BP1–m6A–TUBB4B Axis in Liver Fibrosis
2026-08-19
The reference study identifies an IGF2BP1–m6A–TUBB4B regulatory axis that promotes hepatic stellate cell activation by stabilizing TUBB4B mRNA and engaging FAK signaling. Its integrated sequencing, genetic perturbation, and pharmacological experiments provide a useful framework for testing RNA-modification mechanisms in liver fibrosis, while also highlighting the need for in vivo validation.
-
10 mM dNTP Mixture: Assay Precision
2026-08-19
The 10 mM dNTP mixture is more than a convenient PCR nucleotide mix: it can help standardize DNA construction, controls, and interpretation in molecular assays. This guide connects reagent design with evidence from lipid nanoparticle trafficking research while defining practical boundaries and limitations.
-
3-Deazaadenosine hydrochloride in Fibrosis Research
2026-08-18
Use 3-Deazaadenosine hydrochloride as a chemical perturbation tool to connect SAHH-dependent methyl metabolism with hepatic stellate cell behavior. Its value is greatest when paired with IGF2BP1/TUBB4B pathway assays, genetic controls, and careful viability monitoring rather than used as a stand-alone fibrosis readout.
-
AZD1390 Workflows for ATM Kinase Inhibition
2026-08-18
Build mechanism-led AZD1390 assays for radiation response, checkpoint control, and replication stress in glioma and lung cancer models. The workflow also shows how ATM perturbation can be paired with new REV1–DHX36 insights without confusing G-quadruplex biology with direct ATM inhibition.